These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 25817933)
41. Effects of nutritional supplementation with selenium and zinc on natural killer cell activity in hemodialysis patients: a single-arm study. Sada H; Kato A; Sumimoto R; Ohmori H; Ohdan H Int Urol Nephrol; 2016 Aug; 48(8):1377-1378. PubMed ID: 27234218 [No Abstract] [Full Text] [Related]
42. Renal Association Clinical Practice Guideline on haemodialysis. Mactier R; Hoenich N; Breen C Nephron Clin Pract; 2011; 118 Suppl 1():c241-86. PubMed ID: 21555899 [No Abstract] [Full Text] [Related]
43. Adequacy of haemodialysis. Ford E EDTNA ERCA J; 2005; 31(1):4-8; quiz 9. PubMed ID: 16083018 [TBL] [Abstract][Full Text] [Related]
44. Presidential address upon appointment to the Japanese Society for Dialysis Therapy. Minakuchi J Ther Apher Dial; 2013 Jun; 17(3):245-6. PubMed ID: 23735141 [No Abstract] [Full Text] [Related]
45. JAAD grand rounds quiz. Hand ischemia in a hemodialysis patient. Puryear A; Villarreal S; Wells MJ; Vindhya P; Campbell SJ J Am Acad Dermatol; 2014 Feb; 70(2):393-5. PubMed ID: 24438966 [No Abstract] [Full Text] [Related]
46. [Long-term results of dialysis therapy. Is dialysis-related arteriosclerosis limiting therapy?]. Sieberth HG; Kindler J; Vlaho M; Pelzer R Fortschr Med; 1982 Feb; 100(6):199-202. PubMed ID: 6806161 [No Abstract] [Full Text] [Related]
47. Long thrice weekly hemodialysis: the Tassin experience. Charra B; Terrat JC; Vanel T; Chazot C; Jean G; Hurot JM; Lorriaux C Int J Artif Organs; 2004 Apr; 27(4):265-83. PubMed ID: 15163061 [No Abstract] [Full Text] [Related]
48. Cardiac troponin T and end stage renal disease. Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis. Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823 [TBL] [Abstract][Full Text] [Related]
54. [Long-term results of surgical treatment of secondary hyperparathyroidism in patients using a program hemodialysis]. Evmenova TD; Liamina LG Vestn Khir Im I I Grek; 2014; 173(6):52-3. PubMed ID: 25823312 [TBL] [Abstract][Full Text] [Related]
55. This is an exciting time in dialysis patient safety. Introduction. Patel PR Semin Dial; 2013; 26(4):375. PubMed ID: 23859186 [No Abstract] [Full Text] [Related]
56. In our haemodialysis unit when using the Critline haemoscan, there are problems using this device when administrating transfusions. Any ideas on how to solve this? Lopot F EDTNA ERCA J; 2002; 28(4):180. PubMed ID: 12638933 [No Abstract] [Full Text] [Related]
57. Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis. Cheng Y; Tu W; Xiao Q; Chen Y; Hu L; Wu X Int J Cardiol; 2014 Jul; 174(3):780-3. PubMed ID: 24768378 [No Abstract] [Full Text] [Related]
58. Characteristics of 20-year survivors undergoing maintenance hemodialysis. Morimoto S; Nishioka H; Morita T; Jo F; Someya K; Nakahigashi M; Kusabe M; Ueda H; Takahashi N; Iwasaka T; Maki K Ther Apher Dial; 2010 Dec; 14(6):547-51. PubMed ID: 21118361 [TBL] [Abstract][Full Text] [Related]